- Home
- GROY vs OLMA Comparison
GROY vs OLMA Comparison
Compare GROY & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- OLMA
- Stock Information
- Founded
- GROY 2020
- OLMA 2006
- Country
- GROY Canada
- OLMA United States
- Employees
- GROY 16
- OLMA N/A
- Industry
- GROY
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- GROY
- OLMA Health Care
- Exchange
- GROY Nasdaq
- OLMA Nasdaq
- Market Cap
- GROY 618.0M
- OLMA 378.9M
- IPO Year
- GROY 2021
- OLMA 2020
- Fundamental
- Price
- GROY $3.62
- OLMA $5.46
- Analyst Decision
- GROY Strong Buy
- OLMA Strong Buy
- Analyst Count
- GROY 4
- OLMA 5
- Target Price
- GROY $4.58
- OLMA $24.00
- AVG Volume (30 Days)
- GROY 2.5M
- OLMA 450.7K
- Earning Date
- GROY 08-06-2025
- OLMA 08-11-2025
- Dividend Yield
- GROY N/A
- OLMA N/A
- EPS Growth
- GROY N/A
- OLMA N/A
- EPS
- GROY N/A
- OLMA N/A
- Revenue
- GROY $12,376,000.00
- OLMA N/A
- Revenue This Year
- GROY $82.74
- OLMA N/A
- Revenue Next Year
- GROY $51.73
- OLMA N/A
- P/E Ratio
- GROY N/A
- OLMA N/A
- Revenue Growth
- GROY 90.37
- OLMA N/A
- 52 Week Low
- GROY $1.16
- OLMA $2.86
- 52 Week High
- GROY $3.65
- OLMA $13.93
- Technical
- Relative Strength Index (RSI)
- GROY 65.91
- OLMA 54.42
- Support Level
- GROY $2.89
- OLMA $5.54
- Resistance Level
- GROY $3.37
- OLMA $5.85
- Average True Range (ATR)
- GROY 0.15
- OLMA 0.30
- MACD
- GROY 0.01
- OLMA -0.01
- Stochastic Oscillator
- GROY 85.59
- OLMA 51.79
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.